Details of the Drug

General Information of Drug (ID: DM7UJ1I)

Drug Name

FX-107

Synonyms

FX-06; FX-06); FX-06HS; FX-06MRI; FX-108; FX-201; IK-600X program; Bbeta(15-42); FX-06 analogs (transplantation), Fibrex Medical; FX-06 analogs (transplantation), Ikaria; Peptide leukocyte migration inhibitor (reperfusion injury/hemorrhagic shock), Ikaria; Peptide leukocyte migration inhibitor (reperfusion injury/hemorrhagic shock), FIBREX Medical R&D; FX-06 analogs (sepsis, septic shock, Dengue), Fibrex Medical

Indication

Disease Entry	ICD 11	Status	REF
Dengue fever	1D2Z	Preclinical	[1]

Affected Organisms

Humans and other mammals

Cross-matching ID

DrugBank ID: DB05685
TTD ID: D09WVR

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Fibrin (FG)	TTWODQF	FIBA_HUMAN ; FIBB_HUMAN	Inhibitor	[2]

Molecular Interaction Atlas (MIA)

MIA Detail

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023709)
2	FX-06, a fibrin-derived Bbeta15-42 peptide for the potential treatment of reperfusion injury following myocardial infarction. Curr Opin Investig Drugs. 2009 Sep;10(9):997-1003.